Metastatic cancer is cancer that has spread from where it originally started to a different part of the body. If breast cancer cells travel to the liver, for example, the tumor in the liver is still breast cancer, not liver cancer. This distinction matters because treatment targets the original cancer type, regardless of where it ends up. Metastatic cancer is generally classified as stage IV, the most advanced stage.
How Metastatic Cancer Is Named
One of the most confusing things about metastatic cancer is the naming. A colon cancer that spreads to the liver is called “metastatic colon cancer,” not liver cancer. Under the microscope, those liver tumors still look and behave like colon cells. Doctors treat them with therapies designed for colon cancer, not liver cancer, because the biology of the original tumor drives its behavior.
In some cases, cancer is found at a secondary site before anyone knows where it started. A patient might have tumors in the lungs that turn out to be kidney cancer cells, for instance. When the original source can’t be identified at all, it’s classified as cancer of unknown primary, which requires a different diagnostic approach.
How Cancer Spreads to New Sites
Spreading to a distant organ is not simple. Cancer cells have to complete a long chain of steps, and most cells that attempt it don’t survive. First, cells at the original tumor break through the surrounding tissue by producing enzymes that dissolve the structural proteins holding tissue together. Then they enter blood vessels or lymph vessels. Lymph vessels are easier to infiltrate because their walls are thinner.
Once in the bloodstream, cancer cells face new threats. The immune system can destroy them, and the mechanical forces of circulation can kill them. To survive, some cancer cells hijack the body’s clotting system, essentially wrapping themselves in a protective shield of blood-clotting proteins. The few cells that survive then stick to the walls of small blood vessels at a distant organ, push through the vessel wall, and land in new tissue.
The hardest part comes last. The new environment is foreign to the cancer cell. It has to establish a blood supply, communicate with the surrounding tissue, and begin growing. Many cancer cells sit dormant at secondary sites for months or even years before they successfully colonize. This is why metastatic cancer sometimes appears long after the original tumor was treated.
Where Different Cancers Tend to Spread
Cancer doesn’t spread randomly. Each type has preferred destinations, likely because certain organs offer a more hospitable environment for specific cancer cells.
- Breast cancer: bone, brain, liver, lung
- Lung cancer: adrenal gland, bone, brain, liver, the other lung
- Colon cancer: liver, lung, peritoneum (the lining of the abdomen)
- Rectal cancer: liver, lung, peritoneum
- Prostate cancer: adrenal gland, bone, liver, lung
Bone, liver, lung, and brain are the most common landing spots across cancer types. The liver and lungs receive large volumes of blood flow, which likely explains why circulating cancer cells end up there so often.
Symptoms Depend on Where It Spreads
Metastatic cancer sometimes causes no symptoms at first, especially when tumors are small. As they grow, symptoms reflect the organ that’s affected rather than the original cancer.
Cancer that spreads to bone often causes deep, persistent pain in the affected area, and the bone may fracture more easily than normal. Brain metastases can cause headaches, seizures, dizziness, or changes in vision and personality. Liver metastases may cause abdominal swelling, jaundice (yellowing of the skin and eyes), nausea, or unexplained weight loss. Lung metastases can lead to shortness of breath, a persistent cough, or chest pain. Some people first learn their cancer has spread because of symptoms like these, before any scan confirms it.
How Metastatic Cancer Is Found
Doctors use several imaging tools to detect and map metastatic disease. CT scans take cross-sectional images of the body and are often the first choice for checking the chest, abdomen, and pelvis. MRI uses magnetic fields and radio waves to produce highly detailed images, making it particularly useful for the brain and spinal cord. PET scans work differently: you receive an injection of a radioactive glucose tracer, and the scanner highlights areas where cells are consuming more sugar than normal. Because cancer cells tend to burn through glucose faster than healthy cells, they light up on the scan. PET scans are especially helpful for detecting metastases that might be too small to see clearly on CT.
A newer approach, sometimes called a liquid biopsy, analyzes fragments of tumor DNA circulating in the blood. In several studies, these tests detected cancer DNA in blood samples months before traditional imaging could identify a recurrence. Liquid biopsies can also help track whether treatment is working, catching small changes in tumor activity that a CT scan isn’t sensitive enough to reveal. This technology is still evolving but is already used in some clinical settings.
Treatment Goals for Metastatic Cancer
For most cancer types, metastatic disease is not curable in the traditional sense. Treatment focuses on controlling the cancer’s growth, relieving symptoms, and extending life. This is sometimes called palliative intent, though “palliative” doesn’t mean giving up. Palliative care can be given alongside active cancer treatment and often starts early to manage pain, fatigue, and side effects.
Systemic treatments, those that travel through the whole body, are the backbone of metastatic cancer care. These include chemotherapy, immunotherapy, targeted therapy, and hormone therapy, depending on the cancer type. The goal is to shrink tumors or keep them stable for as long as possible. Many people live for years with metastatic cancer, particularly with cancers like breast or prostate that respond well to ongoing treatment.
Oligometastatic Disease
There is an important exception to the “not curable” picture. When cancer has spread to only a small number of sites, typically one to five metastases, it’s called oligometastatic disease. In these cases, doctors may treat the metastases aggressively with surgery or focused radiation, sometimes with the goal of eliminating the cancer entirely. Some experts have proposed that metastatic lesions should reach at least 8 to 10 millimeters in diameter before being classified this way, since very tiny spots may or may not represent active disease. Oligometastatic disease is a relatively new concept in oncology, and outcomes vary, but some patients do achieve long-term remission after local treatment of limited metastases.
How Metastatic Cancer Differs From Recurrence
These terms overlap but aren’t identical. A recurrence means cancer has come back after a period of remission. If it comes back in or near the original location, it’s a local recurrence. If it comes back in a distant organ, that’s both a recurrence and metastatic disease. Cancer can also be metastatic from the very first diagnosis, meaning it had already spread by the time it was detected. Roughly 1 in 5 cancers are diagnosed at stage IV, depending on the type.
The distinction matters because local recurrence is often still curable with surgery or radiation, while distant metastatic disease usually requires systemic treatment. Knowing whether cancer is local, regional (spread to nearby lymph nodes), or metastatic shapes every treatment decision that follows.